Pathway analysis performed with the genes identified as potentially upregulated due to changes in chromatin accessibility were associated with several known oncogenic signaling pathways involved in tumor growth, metastasis, and cancer drug resistance, such as Ras signaling (21, 53), the MAPK pathway (12, 54), and PI3–AKT signaling (55, 56). The gene discussed is AKT1; the disease is cancer.